Astrazeneca type 2 diabetes drug approved for use by US FDA

30th Oct 2014 07:48

Astrazeneca's Xigduo XR type 2 diabetes treatment has been approved for use in adults by the US Food and Drug Administration (FDA).The drug, which is already approved in Australia, is taken as a once-daily tablet that removes glucose from the body via the kidneys."The addition of Xigduo XR to our US diabetes portfolio is further evidence of Astrazeneca's commitment to develop new treatment options for patients with type 2 diabetes," said Elisabeth Björk, Astra's head of cardiovascular & metabolism division, said."The approval [...] provides prescribers and adult patients with another treatment choice, supporting a more personalised approach to disease management."Shares rose 0.81% to 4,480p early on.